The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
10,13-Dimethyl-dodecahydro-20-oxa-cyclopropa[4,5]cyclopenta[a]phenanthrene-3,17-dione ID: ALA3138000
PubChem CID: 76329470
Max Phase: Preclinical
Molecular Formula: C19H26O3
Molecular Weight: 302.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC12CC[C@H]3[C@@H](CCC45O[C@H]4C(=O)CCC35C)[C@@H]1CCC2=O
Standard InChI: InChI=1S/C19H26O3/c1-17-8-6-13-11(12(17)3-4-15(17)21)5-10-19-16(22-19)14(20)7-9-18(13,19)2/h11-13,16H,3-10H2,1-2H3/t11-,12-,13-,16-,17?,18?,19?/m0/s1
Standard InChI Key: LIMBPOMDHZQBJH-IPCCMEBKSA-N
Molfile:
RDKit 2D
26 30 0 0 1 0 0 0 0 0999 V2000
11.5146 -9.3629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8041 -9.7612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3770 -10.3473 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.5151 -8.5362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6719 -7.3081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2258 -8.1172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6588 -8.1389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9359 -8.5414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2247 -9.7745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0940 -9.3620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4571 -7.0677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9618 -6.8922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8052 -8.1162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9478 -9.3638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2388 -7.2947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4438 -8.4011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0945 -8.5353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9303 -7.7409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3709 -9.7727 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.7193 -6.2869 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.5158 -7.7054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6724 -6.4856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3532 -7.6095 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
13.8098 -9.0466 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
13.7524 -9.1440 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
10.1895 -10.5620 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 1 1 0
7 5 1 0
6 4 1 0
8 7 1 0
8 14 1 0
9 1 1 0
2 10 1 0
11 5 1 0
12 15 1 0
13 4 1 0
14 9 1 0
6 15 1 0
7 16 1 0
17 13 1 0
18 16 1 0
19 10 2 0
20 11 2 0
21 4 1 0
22 5 1 0
2 3 1 0
6 8 1 0
10 17 1 0
5 12 1 0
18 11 1 0
6 23 1 6
8 24 1 1
7 25 1 6
2 26 1 6
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 302.41Molecular Weight (Monoisotopic): 302.1882AlogP: 3.30#Rotatable Bonds: ┄Polar Surface Area: 46.67Molecular Species: NEUTRALHBA: 3HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 3.42CX LogD: 3.42Aromatic Rings: ┄Heavy Atoms: 22QED Weighted: 0.65Np Likeness Score: 2.47
References 1. Marsh DA, Brodie HJ, Garrett W, Tsai-Morris CH, Brodie AM.. (1985) Aromatase inhibitors. Synthesis and biological activity of androstenedione derivatives., 28 (6): [PMID:4009601 ] [10.1021/jm00383a017 ]